Contact your healthcare provider immediately if these occur
[12] IMPORTANT SAFETY INFORMATION : Contact your healthcare provider immediately if you experience: Severe, persistent abdominal pain, with or without vomiting (possible pancreatitis) Pain in the upper right abdomen, fever, or yellowing of skin/eyes (possible gallbladder problems) Minimal urination, dizziness, or extreme thirst (possible kidney problems) Severe abdominal distention or inability to pass gas or stool (possible intestinal obstruction) Persistent vomiting or diarrhea can lead to dehydration and electrolyte imbalances requiring medical attention
The thinner consistency means you can sip it without needing a full bottle to chase it
De Ita JR, Castilla-Cortzar I, Aguirre GA, Snchez-Yago C, Santos-Ruiz MO, Guerra-Menndez L, Martn-Estal I, Garca-Magario M, Lara-Daz VJ, Puche JE, Muoz U
In simple terms: tirzepatide primarily focuses on appetite suppression and metabolic regulation, while retatrutide may influence both appetite and calorie burning
Healthcare providers are already reporting strong interest in the new treatment
